Shore Capital Partners, a healthcare private equity firm, has sold ClearPath Diagnostics, a laboratory diagnostics service provider, to Laboratory Corporation of America (LabCorp).

The acquisition will combine the acquirer’s comprehensive women's health service offering with ClearPath’s local expertise to offer best in-class treatment for LabCorp’s obstetric and gynaecology customers.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Winston & Strawn was the legal advisor for the transaction.

"The acquisition enables Compass Health to deliver better value to its customers by offering its products at lower prices."

In a move expand its ophthalmic product portfolio, specialty surgical developer, Katena Products, has acquired Eagle Vision, a dry eye care and punctal plugs products developer based in Chicago, US.

The acquisition is the second important addition to Katena in 2016 and is a part of its strategy to serve its customers better by expanding its existing product lines and through additional acquisitions.

Compass Health Brands, a medical equipment manufacturer based in Ohio, US, has completed the purchase of Garden City Medical, a subsidiary of Invacare Corporation and distributor of single-use products, in a $13.8m cash transaction.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The acquisition enables Compass Health to deliver better value to its customers by offering its products at lower prices.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact